Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Fusion of cells
Reexamination Certificate
2000-02-16
2002-11-05
McKelvey, Terry (Department: 1636)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Fusion of cells
C435S455000
Reexamination Certificate
active
06475794
ABSTRACT:
BACKGROUND OF THE INVENTION
The problem with humans and other mammals, at least from a genetic diagnostic perspective, is that they are diploid. Mutations in one allele, such as those responsible for all dominantly inherited syndromes, are always accompanied by the wild-type sequence of the second allele. Though many powerful techniques for genetic diagnosis have been developed over the past decade, all are compromised by the presence of diploidy in the template. For example, the presence of a wild-type band of the same electrophoretic mobility as a mutant band can complicate interpretation of sequencing ladders, especially when the mutant band is of lower intensity. Deletions of a segment of DNA are even more problematic, as in such cases only the wild-type allele is amplified and analyzed by standard techniques. These issues present difficulties for the diagnosis of monogenic diseases and are even more problematic for multigenic diseases, where causative mutations can occur in any of several different genes. Such multigenism is the rule rather than the exception for common predisposition syndromes, such as those associated with breast and colon cancer, blindness, and hematologic, neurological, and cardiovascular diseases. The sensitivity of genetic diagnostics for these diseases is currently suboptimal, with 30% to 70% of cases refractory to genetic analysis.
There is a need in the art for simply separating and analyzing individual alleles from human and other mammalian cells.
SUMMARY OF THE INVENTION
It is an object of the invention to provide a method for detecting mutations in a gene of interest on a human or other mammalian chromosome.
It is another object of the invention to provide a method for making test cells suitable for sensitive genetic testing.
It is yet another object of the invention to provide a population of fused cell hybrids which are useful for genetic analysis.
These and other objects of the invention are provided by one or more of the embodiments described below. In one embodiment a method of detecting mutations in a gene of interest of a human or other mammal is provided. Cells of a human or other mammal are fused to rodent cell recipients to form human-rodent or other mammal-rodent cell hybrids. Fused cell hybrids are selected by selecting for a first marker contained on a rodent chromosome and for a second marker contained on a first human or other mammalian chromosome, forming a population of fused cell hybrids. A subset of hybrids are detected among the population of fused cell hybrids. The hybrids are haploid for a second human other mammalian chromosome which is not the same chromosome as the first human or other mammalian chromosome and which was not selected. The subset of hybrids are tested to detect a gene, an mRNA product of said gene, or a protein product of said gene. The gene resides on the second human or other mammalian chromosome. Diminished amounts of the mRNA or protein product or altered properties of the gene, mRNA, or protein product indicate the presence of a mutation in the gene in the human or other mammal.
According to another embodiment, a method is disclosed which provides test cells for genetic testing. The test cells are haploid for human or other mammalian genes. Cells of a human or other mammal are fused to transformed, diploid, rodent cell recipients to form human-rodent or other mammal-rodent cell hybrids. Fused cell hybrids are selected by selecting for a marker on each of a first human or other mammalian chromosome and a rodent chromosome, forming a population of cells which stably maintain one or more human or other mammalian chromosomes in the absence of selection for the human or other mammalian chromosomes. Cells which are haploid for a second human or other mammalian chromosome which is distinct from the first human or other mammlian chromosome are detected among the population of cells; the second human or other mammalian chromosome was not selected.
Also provided by the present invention is a population of rodent-human or rodent-other mammalian hybrid cells wherein each homolog of at least 2 human or other mammalian autosomes is present in haploid form in at least one out of one hundred of the cells.
The present invention thus provides the art with a method which can be used to increase the sensitivity and effectiveness of various diagnostic and analytic methods by providing hybrid cells to analyze which are haploid for one or more genes of interest. The human or other mammalian chromosome content of the hybrid cells is stable and uniform.
REFERENCES:
patent: 5612201 (1997-03-01), De Plaen et al.
Pietenpol et al. Mammalian cells resistant to tumor suppressor genes. PNAS vol. 93:8390-8394.*
Tindall et al. Complementation to mismatch repair gene defects by chromosome transfer. Mutation Res. vol. 402:15-22.*
Nyormoi et al. Proliferating hybrid cells froed between rat spematids and an established line of mouse fibroblasts. J. Cell Sci. vol. 13:863-878.*
Tolsma et al. Transformation of NIH/3T3 to anchorage independence by H-Ras is accompanied by loss of suppressor activity. Exp. Cell Res. vol. 205:232-239.*
McDaniel et al. Confirmation of homozygosity for a single nucleotide substitution mutation in a cockayne syndrome patient using monoallelic mutation analysis in somatic cell hybrids. Human Mutation vol. 10:317-321.*
Kayes et al. Deletion spanning the neurofibromatosis I gene: Identification and phenotype of five patients. Am. J. Hum. Genet. Vo. 54:424-436.*
Leach, F.S. et al.; “Mutations of the Muts Homolog in Heredity Nonpolyposis Colorectal Cancer”; Cell, vol. 75, No. 6, Dec. 1993, pp. 1215-1225.
Hosoi, E. et al.; “A Human-Mouse Hybrid Cell Line Expressing Both Human Leukocyte and Histocompatibility-2 Antigens”, Japanese Journal of Physiology, vol. 40, No. 1, 1990, pp. 297-304, 1990.
Yan, Hai et al.; “Conversion of Diploidy to Hapliody”, Nature (London), vol. 403, No. 6771, Feb. 2000, pp. 723-724.
Santachiara et al., “Genetic Analysis with Man-Mouse Somatic Cell Hybrids”,Nature, vol. 227, pp. 248-251 (1970).
Lugo et al., “Isolation of Microcell Hybrid Clones Containing Retroviral Vector Insertions into Specific Human Chromosomes”,Molecular and Cellular Biology, pp. 2814-2820 (1987) vol. 7(8).
Saxon et al., “Selective Transfer of Individual Human Chromosomes to Recipient Cells”,Molecular and Cellular Biology, pp. 140-146, (1995) vol. 5(1).
Campbell et al., “Trans-Acting Factors in Chromosomal Instability”,Cancer Genetics Cytogenetics, vol. 48, pp. 89-100 (1990).
Cuthbert et al., “Construction and characterization of a highly stable human:rodent monochromosomal hybrid panel for genetic complementation and genome mapping studies”,Cytogenetics Cell Genetics, vol. 71, pp. 68-76 (1995).
Douglas et al., “Experimentally-derived haplotypes substantially increase the efficiency of linkage disequilibrium studies”,Nature Genetics, vol. 28, pp. 361-364 (2001).
Langer et al., “Facilitating haplotype analysis by fully automated analysis of all chromosomes in human-mouse hybrid cell lines”,Cytogenetics Cell Genetics, vol. 93, pp. 11-15 (2001).
Zuna et al., “Heterogeneity of Karyotype and Growth Potential in Simian Virus 40-Transformed Chinese Hamster Cell Clones”,J. Natl. Cancer Inst., vol. 58, No. 5, pp. 1463-1479 (1977).
Grinchuk et al., “Pleiotropic Alterations of Caryotype Structure of Fibroblasts of CHL V-79 RJK Chinese Hamster, Related to Their Acquiring Resistance to Etoposide—Inducer of Apoptosis”,Tsitologia(Cytology), vol. 41, No. 2, pp. 1-9 (1999).
Thacker, J., “The Chromosomes of a V79 Chinese Hamster Line and a Mutant Subline Lacking HPRT Activity”,Cytogenetics Cell Genetics, vol. 29, pp. 16-25 (1981).
Allderdice, et al., “Chromosome Analysis of two Related Heteroploid Mouse Cell Lines by Quinacrine Fluorescence”,J. Cell Sci., vol. 12, pp. 263-274 (1973).
Russell, et al., Karyotypic Analyses of Parental and Hybrid Intraspecific Mouse Cells, A9/B82, by Giemsa- and Centromeric-Banding,J. Cell Sci., vol. 25, pp. 59-71 (1977).
Weiss et al., “Human-Mouse Hybrid Cell Lines Containing Partial Complements of Human Chro
Kinzler Kenneth W.
Papadopoulos Nickolas
Vogelstein Bert
Yan Hai
Banner & Witcoff , Ltd.
McKelvey Terry
Sandals William
The Johns Hopkins University
LandOfFree
Converting diploidy to haploidy for genetic diagnosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Converting diploidy to haploidy for genetic diagnosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Converting diploidy to haploidy for genetic diagnosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2986561